M. Gwilt

发表

Reflections on the 50th annual meeting of the EASD

M. Gwilt, 2014 .

Comparative Antifibrillatory Effects of d- and dl-Sotalol in Normal and Ischaemic Ventricular Muscle of the Cat

Y. Kwan, R. Wadsworth, K. Kane, 1990, Journal of cardiovascular pharmacology.

Characteristics of multiple sclerosis in the Middle East with special reference to the applicability of international guidelines to the region

M. Freedman, M. Szólics, D. Deleu, 2014, The International journal of neuroscience.

UK-68,798: a novel, potent and highly selective class III antiarrhythmic agent which blocks potassium channels in cardiac cells.

J. Arrowsmith, M. Gwilt, P. Cross, 1991, The Journal of pharmacology and experimental therapeutics.

Electrophysiologic Properties of UK‐66,914, a Novel Class III Antiarrhythmic Agent

M. Gwilt, P. Cross, R. Burges, 1991, Journal of cardiovascular pharmacology.

Calcium Channel Blocking Properties of Amlodipine in Vascular Smooth Muscle and Cardiac Muscle In Vitro: Evidence for Voltage Modulation of Vascular Dihydropyridine Receptors

M. Gwilt, S. Campbell, P. Cross, 1987, Journal of cardiovascular pharmacology.

Vascular complications in prediabetes and type 2 diabetes: a continuous process arising from a common pathology

U. Gottwald-Hostalek, M. Gwilt, Ulrike Gottwald-Hostalek, 2022, Current medical research and opinion.

NORTHEASTERN UNIVERSITY BOUVE COLLEGE OF HEALTH SCIENCES DEPARTMENT OF PHARMACEUTICAL SCIENCES BOSTON, MA Master’s Thesis CHARACTERIZING THE EXPRESSION OF TISSUE SPECIFIC ISOFORMS AND POST- TRANSLATIONAL MODIFICATIONS OF TETRASPANIN CD82 IN MUSCLE STEM CELLS by KATLYNN

E. Gussoni, R. Loring, M. Gwilt, 2017 .

K+ ‐Channel blockers and coronary vasoconstriction in guinea‐pig perfused hearts in‐vitro

M. Gwilt, C. Henderson, J. Orme, 1993, The Journal of pharmacy and pharmacology.

Pharmacological studies of K+ loss from ischaemic myocardium in vitro: roles of ATP-dependent K+ channels and lactate-coupled efflux.

M. Gwilt, C. Henderson, B. Norton, 1993, European journal of pharmacology.

Effects of drugs on ventricular fibrillation and ischaemic K+ loss in a model of ischaemia in perfused guinea-pig hearts in vitro.

M. Gwilt, C. Henderson, J. Orme, 1992, European journal of pharmacology.

Electropharmacology of dofetilide, a new class III agent, in anaesthetised dogs.

A. Milne, M. Gwilt, A. M. Solca, 1992, European journal of pharmacology.

Therapeutic Use of Metformin in Prediabetes and Diabetes Prevention

U. Hostalek, M. Gwilt, S. Hildemann, 2015, Drugs.

The effect of chronic neostigmine treatment on channel properties at the rat skeletal neuromuscular junction

M. Gwilt, D. Wray, 1986, British journal of pharmacology.

Action of antibodies directed against the acetylcholine receptor on channel function at mouse and rat motor end‐plates.

P. Whiting, A. Vincent, J. Dolly, 1988, The Journal of physiology.

Diabetes, Metformin and the Clinical Course of Covid-19: Outcomes, Mechanisms and Suggestions on the Therapeutic Use of Metformin

Clifford J. Bailey, M. Gwilt, 2022, Frontiers in Pharmacology.

Lambert-Eaton myasthenic syndrome: electrophysiological evidence for a humoral factor.

N. Murray, A. Vincent, J. Newsom-Davis, 1982, Muscle & nerve.

This house believes that sulphonylureas should not be used routinely as second-line treatments for patients with type 2 diabetes

R. Holman, R. Ryder, M. Gwilt, 2016 .

Preconception Antidiabetic Drugs in Men and Birth Defects in Offspring

P. Rossing, M. Gwilt, 2022, Annals of Internal Medicine.

Selective class III antiarrhythmic agents. 1 Bis(arylalkyl)amines.

M Gwilt, J. Arrowsmith, P E Cross, 1990, Journal of medicinal chemistry.

Treating venous leg ulceration with complementary therapy.

M. Gwilt, J. Athis, 2000, Community nurse.

Biochemical and electrophysiological properties of antibodies against pure acetylcholine receptor from vertebrate muscles and its subunits from Torpedo in relation to experimental myasthenia

J. Dolly, F. Mehraban, M. Gwilt, 1983, Neurochemistry International.